| |
| |
|
| Insider
Information: |
Hoberman Kenneth |
| Relationship: |
Director |
| City: |
New York |
| State: |
NY |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
3 |
|
| Direct
Shares |
297,825 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$4,154,767 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
297,825 |
|
|
| Total
Value |
$4,154,767 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
5
|
|
Stock
price went up :
|
0
|
5
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
5.0
|
| Percentage
Gain/Loss : |
0.0%
|
 402.2%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Stemline Therapeutics Inc |
STML |
Chief Operating Officer |
2020-06-10 |
0 |
|
0 |
Premium* |
|
|
TG Therapeutics Inc |
TGTX |
Director |
2023-09-28 |
242,685 |
|
0 |
Premium* |
|
|
Nuvectis Pharma, Inc. |
NVCT |
Director |
2022-05-12 |
55,140 |
|
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
71 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 3
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| STML |
Stemline Therapeutics Inc |
Chief Operating OfficerOfficer |
• – – |
2013-03-25 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
19,288 |
|
- |
|
| TGTX |
TG Therapeutics Inc |
Director |
– • – |
2014-12-15 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
64,223 |
|
- |
|
| NVCT |
Nuvectis Pharma, Inc. |
Director |
– • – |
2022-02-08 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
49,140 |
|
- |
|
| STML |
Stemline Therapeutics Inc |
Chief Operating Officer |
• – – |
2014-02-14 |
4 |
A |
$0.00 |
$0 |
D/D |
14,985 |
102,785 |
0 |
- |
|
| STML |
Stemline Therapeutics Inc |
Chief Operating Officer |
• – – |
2015-03-06 |
4 |
A |
$0.00 |
$0 |
D/D |
24,379 |
112,321 |
0 |
- |
|
| TGTX |
TG Therapeutics Inc |
Director |
– • – |
2015-06-04 |
4 |
A |
$0.00 |
$0 |
D/D |
4,667 |
74,446 |
0 |
- |
|
| STML |
Stemline Therapeutics Inc |
Chief Operating Officer |
• – – |
2015-12-31 |
4 |
GD |
$0.00 |
$0 |
D/D |
60,000 |
62,119 |
0 |
- |
|
| STML |
Stemline Therapeutics Inc |
Chief Operating Officer |
• – – |
2016-01-07 |
4 |
A |
$0.00 |
$0 |
D/D |
150,000 |
212,562 |
0 |
- |
|
| STML |
Stemline Therapeutics Inc |
Chief Operating Officer |
• – – |
2016-02-24 |
4 |
A |
$0.00 |
$0 |
D/D |
87,985 |
299,044 |
0 |
- |
|
| TGTX |
TG Therapeutics Inc |
Director |
– • – |
2016-07-06 |
4 |
A |
$0.00 |
$0 |
D/D |
12,459 |
86,905 |
0 |
- |
|
| STML |
Stemline Therapeutics Inc |
Chief Operating Officer |
• – – |
2017-03-09 |
4 |
A |
$0.00 |
$0 |
D/D |
131,469 |
409,143 |
0 |
- |
|
| TGTX |
TG Therapeutics Inc |
|
– • – |
2017-06-16 |
4 |
A |
$0.00 |
$0 |
D/D |
15,000 |
101,905 |
0 |
- |
|
| STML |
Stemline Therapeutics Inc |
Chief Operating Officer |
• – – |
2018-03-08 |
4 |
A |
$0.00 |
$0 |
D/D |
70,303 |
439,581 |
0 |
- |
|
| TGTX |
TG Therapeutics Inc |
|
– • – |
2018-06-26 |
4 |
A |
$0.00 |
$0 |
D/D |
15,000 |
116,905 |
0 |
- |
|
| STML |
Stemline Therapeutics Inc |
Chief Operating Officer |
• – – |
2018-09-12 |
4 |
A |
$0.00 |
$0 |
D/D |
275,000 |
686,034 |
0 |
- |
|
| STML |
Stemline Therapeutics Inc |
Chief Operating Officer |
• – – |
2019-02-06 |
4 |
A |
$0.00 |
$0 |
D/D |
148,678 |
795,330 |
0 |
- |
|
| TGTX |
TG Therapeutics Inc |
|
– • – |
2019-09-17 |
4 |
A |
$0.00 |
$0 |
D/D |
27,048 |
143,953 |
0 |
- |
|
| STML |
Stemline Therapeutics Inc |
Chief Operating Officer |
• – – |
2020-02-10 |
4 |
A |
$0.00 |
$0 |
D/D |
208,417 |
809,502 |
0 |
- |
|
| STML |
Stemline Therapeutics Inc |
Chief Operating Officer |
• – – |
2020-06-10 |
4 |
D |
$0.00 |
$0 |
D/D |
(1,374,352) |
0 |
0 |
- |
|
| STML |
Stemline Therapeutics Inc |
Chief Operating Officer |
• – – |
2020-06-10 |
4 |
A |
$0.00 |
$0 |
D/D |
600,000 |
1,374,352 |
0 |
- |
|
| TGTX |
TG Therapeutics Inc |
Director |
– • – |
2020-06-22 |
4 |
A |
$0.00 |
$0 |
D/D |
15,000 |
158,953 |
0 |
- |
|
| TGTX |
TG Therapeutics Inc |
Director |
– • – |
2021-06-18 |
4 |
A |
$0.00 |
$0 |
D/D |
20,000 |
178,953 |
0 |
- |
|
| TGTX |
TG Therapeutics Inc |
Director |
– • – |
2022-07-20 |
4 |
A |
$0.00 |
$0 |
D/D |
43,732 |
222,685 |
0 |
- |
|
| TGTX |
TG Therapeutics Inc |
Director |
– • – |
2023-09-28 |
4 |
A |
$0.00 |
$0 |
D/D |
20,000 |
242,685 |
0 |
- |
|
| STML |
Stemline Therapeutics Inc |
Chief Operating Officer |
• – – |
2017-12-18 |
4 |
S |
$14.75 |
$590 |
D/D |
(40) |
398,832 |
0 |
- |
|
71 Records found
|
|
Page 1 of 3 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
